Our Mission: Decoding Your Health For A Longer Life
Epinostics is a UK-based diagnostics spin-out from King’s College London, built on eight years of cutting-edge research into biomarker extraction and analysis. We are developing a disruptive platform technology that enables rapid, non-invasive sampling of biomarkers directly from the skin.
Our patented device opens up a new frontier in diagnostics by safely and efficiently collecting samples across all age groups — including individuals with dermatological conditions — without the need for invasive procedures. This dramatically broadens access and reduces the burden on patients and clinicians alike.
At Epinostics, our mission is to decode your health for a longer life. This required that we revolutionize diagnostic medicine, improve patient outcomes, and contribute to healthier, longer lives on a global scale.
Epinostics is a highly skilled team of experts, combining scientific, manufacturing and clinical knowledge, with a track record of success in developing and delivering numerous skin-focused technologies.
Transforming Biomarker Access
Current biomarker collection techniques are often invasive, labour-intensive, and contain high proportions of relic data points. Our proprietary method uses transient skin stretching to briefly open appendages in the skin, enabling targeted biomarker extraction in a simple, scalable, and patient-friendly way.
We combine this novel sampling technique with state-of-the-art multi-omic analysis, enabling us to identify thousands of biomarkers that reflect both local and systemic health. This platform has broad applications across early disease detection, precision medicine, and real-time health monitoring.
Epinostics is uniquely positioned to lead a new era of diagnostics—minimally invasive, data-rich, and accessible at scale.